Lead Partner
Artia Solutions
Artia Solutions provides drug manufacturers with the resources, guidance, and support needed to successfully launch or manage their medical or pharmacy benefit products within the Medicaid and Medicaid Managed Care marketplaces. Our vision is to ultimately enhance the lives of patients by creating access to essential medications.
Expertise Partner
Milliman
Milliman is a trusted partner to cell and gene therapy (CGT) developers navigating the complexities inherent in pricing, reimbursement, and access. Our thought leaders leverage deep experience in the primary and secondary payer space to inform the strategies we develop that enable patient access. In addition to advising CGT developers, Milliman DNA Gene and Cell Therapy Forecasting, an on-line software product, provides insight into key uncertainties for CGT and dynamic modeling that supports payers in pricing, underwriting and product development for CGT coverage.
Expertise Partner
Uniphar
Uniphar is a trusted global partner to pharma, working to improve global patient access to medicines. Over the last 5 years, we have built unparalleled experience supporting our partners to accelerate patient access to cell and gene therapies around the globe.
Uniphar’s CGT experts harness the capabilities, infrastructure and experience of a diversified pharmaceutical service provider with more than 55 years’ building success stories with 200+ multinational clients.
Our understanding of the complex CGT requirements, market dynamics and barriers to access have allowed us to develop a fit-for-purpose CGT access platform which has delivered tailored solutions allowing more than 500 patients to access CGT treatments around the world.
Uniphar Pharma comprises Uniphar | Access, Uniphar | Medical, and Uniphar | Commercial – together our combined capabilities make us your trusted partner to unlock access to innovative therapies in countries where you might think it unachievable.
Hosting Partner
Occam Health Services
Occam Health Services, is a full-service hub provider that specializes in patient support services for patient populations with complex disease states and patient journeys. Our combination of expertise and technology eases the burden on patients while streamlining access to multifaceted therapies. Using a patient-first and technology-forward approach, we provide reimbursement support, patient assistance, bridge programs, nursing support, field reimbursement support, sales teams ( even virtual models), etc., and a whole host of digital solutions for various stakeholders.
Event Partner
Lyfegen
Lyfegen is an independent provider of rebate management software designed for the healthcare industry. Lyfegen solutions are used by health insurances, governments, hospital payers, and pharmaceutical companies around the globe to dramatically reduce the administrative burden of managing complex drug pricing agreements and to optimize rebates and get better value from those agreements. Lyfegen maintains the world’s largest digital repository of innovative drug pricing models and public agreements and offers access to a robust drug pricing simulator designed to dynamically simulate complex drug pricing scenarios to understand full financial impact. Headquartered in Basel, Switzerland, the company was founded in 2018 and has a market presence in Europe, North America, and the Middle East.
Innovation Partner
GuideHouse
Guidehouse is a leading global consultancy with a significant footprint in healthcare, serving both public and commercial sectors. Our specialized Cell & Gene Therapies practice has successfully guided over 25 companies and 50+ assets, including launch of 8 marketed therapies. We create tailored solutions for Cell & Gene Therapies, encompassing evidence generation plans, alternative payment models, and comprehensive pricing & reimbursement strategies that support the unique value and drive sustainable access for these innovative therapies
Event Partner
Digital Health Policy Strategies
Digital Health Policy Strategies is a healthcare consultancy specializing in reimbursement, market access, and policy navigation for innovative therapies, including cell and gene therapies. We cut through the noise to connect policies, innovations, and outcomes, helping clients secure coverage, coding, and payment strategies. Our data-driven approach identifies key opportunities, creates actionable steps, and drives execution to advance patient access and commercialization success. We pave new avenues in healthcare to navigate complex regulatory and reimbursement landscapes effectively.
Media Partner
BioPharma Asia
BioPharma Asia aims to keep its readers abreast of all developments in Manufacturing, Development, Quality Assurance, Outsourcing, and Regulatory Affairs, with only the highest quality articles and webinars written and presented by the most respected authors/presenters, associated with only end-user companies. So, ensuring the information will always be guaranteed to remain timely, informative, and unbiased.
Media Partner
Gene Therapy Net
Gene Therapy Net is the information resource for basic and clinical research in gene therapy, and the site serves as a network for the exchange of gene therapy information and breaking news items. Visitors can keep track of the latest scientific papers, conference announcements, gene therapy jobs, regulations, and guidelines."
Media Partner
Cell & Gene Therapy Review
Commonly referred to as the 'next frontier in health care,' cell and gene therapies have quickly become one of the most promising areas in pharma. With a brimming pipeline, increasing number of approvals and a growing patient population, developers are under pressure to meet the sector's many formidable challenges. Cell & Gene Therapy Review is designed to provide professionals with the information they need to optimize processes, reduce costs and ultimately, get lifesaving therapies to the patients who need them.
Editorial Mission: To provide industry professionals with the latest information on the tools, technologies, and processes to discover, develop, and manufacture quality cell and gene therapies safely and efficiently.
Get Involved:
FINLAY COOMBES
Partnerships Director